News & Innovations

News and innovations published by German exhibitors

  back to overview

ISPE’s 2019 Facility of the Year Award for Operational Excellence won by partners Exyte and Kantonsapotheke Zurich

The award was announced on 2 April 2019 at the ISPE Europe Annual Conference in Dublin, Ireland. Exyte sincerely congratulates its client on this success. The facility Kantonsapotheke Zurich (KAZ) is a true shift forward, as a confluence of ideas, leadership, technology, finance and marketplace. It leads the very concept of hospital pharmacies into the future and establishes benchmarks of operational excellence never seen before in patient focused facilities.

ISPE’s annual FOYA Awards identify the best projects around the world in Life Science, recognizing innovation and creativity in technology, regulatory compliance, operations and business practices. Exyte is pleased to have been the design-build partner bringing this project from concept to startup.
“Working in concert with the leadership team of Kantonapotheke Zurich, Exyte provided engineering, procurement, construction management and validation that led to the development of this technologically-advanced facility”, outlines François Abiven, President Life Sciences & Chemicals at Exyte....

The KAZ has replaced and integrated two outdated hospital pharmacies that had been unable to continue serving the progressive needs of the community. Today, the facility provides the Canton of Zurich hospital system a range of oral, dermal and parenteral formulations, often with patient-specific recipes. It is highly flexible, adaptable and expandable to easily and quickly accommodate new functions, such as the rapidly emerging field of personalized medicine. All products are manufactured under industrial cGMP conditions, a major step change that is new to hospital pharmacies and their workers.

Exhibitor: Exyte AG


We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection